日本語English简体中文 繁體中文

4574 TAIKO PHARMACEUTICAL CO.,LTD.大幸薬品TSE Prime / Pharmaceuticals

0 posts

TAIKO PHARMACEUTICAL CO.,LTD. (4574) at a glance

Code
4574
Company
TAIKO PHARMACEUTICAL CO.,LTD.
Local name
大幸薬品
Market
TSE Prime
Sector
Pharmaceuticals
Share price
¥244 -10.0 (-3.94%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

TAIKO PHARMACEUTICAL CO.,LTD. (4574) Stock Price HistoryNear a 52-week low

TAIKO PHARMACEUTICAL CO.,LTD. closed at ¥244 on Nov 20, 2026, −7.6% over 1 month, −16.2% over 1 year.

2026-11-13 2026年12月期(FY2026) 第3四半期決算短信〔日本基準〕(連結)¥266¥244Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥266Nov 5
1-Month Low¥244Nov 20
1-Week Change−7.2%vs Nov 13
1-Month Change−7.6%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥92,424 today (−7.6%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved −7.6%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥244−10−3.94%
Nov 19 (Thu)¥254−4−1.55%
Nov 17 (Tue)¥258+0+0.00%
Nov 16 (Mon)¥258−5−1.90%
Nov 13 (Fri)¥263−2−0.75%
Nov 12 (Thu)¥265+6+2.32%
Nov 11 (Wed)¥259−2−0.77%
Nov 10 (Tue)¥261+1+0.38%
Nov 9 (Mon)¥260+0+0.00%
Nov 6 (Fri)¥260−6−2.26%
2026-11-13 2026年12月期(FY2026) 第3四半期決算短信〔日本基準〕(連結)¥270¥244Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥270Aug 25
3-Month Low¥244Nov 20
1-Month Change−7.6%vs Oct 20
3-Month Change−9.0%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥91,045 today (−9.0%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved −9.0%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥244−10−3.94%
Nov 19 (Thu)¥254−4−1.55%
Nov 17 (Tue)¥258+0+0.00%
Nov 16 (Mon)¥258−5−1.90%
Nov 13 (Fri)¥263−2−0.75%
Nov 12 (Thu)¥265+6+2.32%
Nov 11 (Wed)¥259−2−0.77%
Nov 10 (Tue)¥261+1+0.38%
Nov 9 (Mon)¥260+0+0.00%
Nov 6 (Fri)¥260−6−2.26%
2026-11-13 2026年12月期(FY2026) 第3四半期決算短信〔日本基準〕(連結)¥284¥244May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥284Jun 29
6-Month Low¥244Nov 20
3-Month Change−9.0%vs Aug 20
6-Month Change−4.3%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥95,686 today (−4.3%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved −4.3%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥244−6.2%
Oct 2026¥260+2.4%
Sep 2026¥254−3.4%
Aug 2026¥263+4.0%
Jul 2026¥253−10.6%
Jun 2026¥283+10.5%
May 2026¥256−12.3%
2026-11-13 2026年12月期(FY2026) 第3四半期決算短信〔日本基準〕(連結)¥316¥244Nov 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥316Feb 27
52-Week Low¥244Nov 20
Year to Date−18.1%vs Dec 30
From 52-Week High−22.8%Feb 27

If you had invested ¥100,000 1 year ago, it would be worth ¥83,849 today (−16.2%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +13.3%, while this stock moved −16.2%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥244−6.2%
Oct 2026¥260+2.4%
Sep 2026¥254−3.4%
Aug 2026¥263+4.0%
Jul 2026¥253−10.6%
Jun 2026¥283+10.5%
May 2026¥256−12.3%
Apr 2026¥292−1.0%
Mar 2026¥295−6.6%
Feb 2026¥316+10.9%
Jan 2026¥285−4.4%
Dec 2025¥298−1.3%
Nov 2025¥302―
¥478¥243Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥478Jul 8, 2024
3-Year Low¥243Jun 9, 2025
Annualized Return−8.4%
Max Drawdown−49.2%

If you had invested ¥100,000 3 years ago, it would be worth ¥76,730 today (−23.3%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved −23.3%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥244−18.1%
2025¥298―
¥824¥243Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥824Dec 27, 2021
5-Year Low¥243Jun 9, 2025
Annualized Return−20.6%
Max Drawdown−70.5%

If you had invested ¥100,000 5 years ago, it would be worth ¥31,525 today (−68.5%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +96.3%, while this stock moved −68.5%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥244−18.1%
2025¥298―
¥2,600¥198Apr 1, 2009Nov 20, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥2,600Jun 2020
All-Time Low¥198May 2012
Total Change−44.5%vs Apr 2009
Annualized Return−3.3%

If you had invested ¥100,000 in Apr 2009, it would be worth ¥55,455 today (−44.5%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +466.7%, while this stock moved −44.5%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥244−18.1%
2025¥298−10.0%
2024¥331+9.2%
2023¥303−23.1%
2022¥394−52.2%
2021¥824−48.9%
2020¥1,612+47.7%
2019¥1,092+68.1%
2018¥649−18.3%
2017¥795+28.7%
2016¥618+1.3%
2015¥610−9.1%
2014¥671−15.9%
2013¥798+181.9%
2012¥283+8.8%
2011¥260−33.6%
2010¥391−38.9%
2009¥641―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Apr 2009). Please check the latest prices before trading.

TAIKO PHARMACEUTICAL CO.,LTD. (4574) financial indicators

PER
22.3
PBR
1.44
ROE
6.45%
Dividend yield
1.43%

See all financial indicators for TAIKO PHARMACEUTICAL CO.,LTD. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of TAIKO PHARMACEUTICAL CO.,LTD. (4574)

Business overview

Together with five subsidiaries, the company runs pharmaceutical, infection control and other businesses. The pharmaceutical business makes over-the-counter drugs centered on 「正露丸」 and 「セイロガン糖衣A」 and sells them in Japan and abroad. 「正露丸」, with a history of more than 120 years, maintains high brand recognition in Japan, and the company also sells the capsule-type 「正露丸クイックC」, the antidiarrheal 「ピシャット下痢止めOD錠」 that can be taken without water, and the quasi-drug 「ラッパ整腸薬BF」. In Japan it sells through pharmacies and drugstores. Overseas, it sells in Hong Kong and China and in Taiwan through subsidiaries, and in the United States, Canada, Thailand, Malaysia and Mongolia through exports via agents. In China it sells to the South China market from its Hong Kong base and is expanding sales channels to East, North and Northeast China.

Summarized from the annual securities report (fiscal year ended December 2025) filed on EDINET.

Position within Pharmaceuticals (79 companies)

Dividend yield1.43%No. 34 in the sector (highest first); median 2.97%
PER22.3xAbove the sector median of 16.5x (No. 26 from the lowest)
PBR1.44xBelow the sector median of 1.86x (No. 26 from the lowest)
ROE6.45%No. 22 in the sector (highest first); median 4.17%
Market cap¥12.3 bnNo. 43 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥3162/27
52-week low¥24411/20
Current position0.0%Where the low is 0% and the high is 100% (close on 11/20: ¥244)
Year to date-18.1%No. 43 of 77 in the sector (best first)
1 year-16.1%

Based on closing prices (adjusted for stock splits, excluding dividends).

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (3).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the TAIKO PHARMACEUTICAL CO.,LTD. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English